Fujifilm Holdings Corp. (OTCMKTS:FUJIY - Get Free Report) was the target of a large increase in short interest in July. As of July 15th, there was short interest totaling 34,100 shares, anincreaseof278.9% from the June 30th total of 9,000 shares. Based on an average daily volume of 310,800 shares, the short-interest ratio is presently 0.1 days. Based on an average daily volume of 310,800 shares, the short-interest ratio is presently 0.1 days.
Fujifilm Stock Performance
Fujifilm stock traded up $0.15 during mid-day trading on Friday, hitting $10.48. The company had a trading volume of 170,827 shares, compared to its average volume of 170,643. The company has a current ratio of 1.40, a quick ratio of 0.92 and a debt-to-equity ratio of 0.14. Fujifilm has a 12-month low of $8.69 and a 12-month high of $13.88. The company's fifty day moving average is $10.65 and its 200-day moving average is $10.40. The company has a market capitalization of $26.07 billion, a price-to-earnings ratio of 9.36, a P/E/G ratio of 3.18 and a beta of 0.67.
Fujifilm (OTCMKTS:FUJIY - Get Free Report) last released its quarterly earnings data on Thursday, May 8th. The technology company reported $0.22 EPS for the quarter, topping the consensus estimate of $0.18 by $0.04. Fujifilm had a return on equity of 7.84% and a net margin of 8.15%. The business had revenue of $6.06 billion for the quarter, compared to analyst estimates of $822.51 billion. Equities research analysts predict that Fujifilm will post 0.66 EPS for the current year.
Wall Street Analyst Weigh In
Separately, Wall Street Zen lowered Fujifilm from a "buy" rating to a "hold" rating in a research report on Friday, May 23rd.
View Our Latest Stock Analysis on Fujifilm
About Fujifilm
(
Get Free Report)
FUJIFILM Holdings Corporation develops, manufactures, sells, and services imaging, healthcare, materials, and business innovation solutions worldwide. The company's Healthcare segment provides products and services, such as medical devices, biomedical contract development and manufacturing organization, pharmaceutical, regenerative medicine, and cosmetics and supplements in the areas of prevention, diagnosis, and treatment.
Featured Stories
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Fujifilm, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Fujifilm wasn't on the list.
While Fujifilm currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.